REFERENCES

1. 1.Sultanpur CM, Deepa K, Kumar SV. Comprehensive review on hba1c in diagnosis of diabetes mellitus.
International Journal of Pharmaceutical Sciences Review and Research 2010; 3(2): 119-22.
2. Diabetes Atlas 2009, IDF, Belgium.
3. Text Book of Diabetes, 3rd edition- vol 1, edited by John C. Pickup and G. Williams, Blackwell Science, 2003, p
5.1-6.14.
4. Rahbar, Blumenfeld O, Ranney HM. Studies of an unusual haemoglobin in patients with diabetes mellitus.
Biochem Biophys Res Commun 1969; 36: 838-43.
5. Huisman TH, Martis EA, Dozy A. "Chromatography of hemoglobin types on carboxymethylcellulose". J. Lab.
Clin. Med. 1958; 52 (2): 312-27. PMID 13564011.
6. Bookchin RM, Gallop PM. "Structure of hemoglobin A1c: nature of the N-terminal beta chain blocking group".
Biochem. Biophys. Res. Commun. 1968;32 (1):86-93. DOI:10.1016/0006-291X(68)90430-0. PMID 4874776.
7. Rahbar S, Blumenfeld O, Ranney HM. "Studies of an unusual hemoglobin in patients with diabetes mellitus".
Biochem. Biophys. Res. Commun. 1969; 36 (5): 838-43. DOI:10.1016/0006-291X(69)90685-8. PMID 5808299.
8. John Pick Up and Gareth Williams, text book of Diabetes, published by Blackwell science 1998; 2: 5.6-5.7.
9. Weykamp C, John WG, Mosca A. A Review of the Challenge in Measuring Hemoglobin A1c. J
Diabetes Sci Technol 2009; 3(3): 439-45.
10.Nathan DM, Turgeon H, Regan S. Relationship between glycated haemoglobin levels and
mean glucose levels over time. Diabetologia 2007; 50: 2239-44.
11.Gillery P, Monboisse JC, Maquart FX, et al. Glyation of proteins as a source of superoxide.
Diab metab 1988; 14: 25-30.
12.Use of Glycated Haemoglobin (HbA1c) in the Diagnosis of Diabetes Mellitus: Abbreviated
Report of a WHO Consultation. World Health Organization 2011.
13.International Expert Committee report on the role of the A1c assay in the diagnosis of
diabetes. Diabetes Care 2009; 32(7): 1327-34. DOI:10.2337/dc09-9033. PMC
2699715.PMID 19502545.
14."Executive summary: Standards of medical care in diabetes-2010". Diabetes Care 2010; 33
(Suppl 1): S4- 10. DOI: 10.2337/dc10-S004. PMC 2797389.PMID 20042774.
15.Nitin S. HbA1c and factors other than diabetes mellitus affecting it. Singapore Med J 2010;
51(8): 616-22.
16.American Diabetes Association (2007). "Standards of medical care in diabetes--2007".
Diabetes Care 2007; 30 (Suppl 1): S4-S41. DOI: 10.2337/dc07-S004. PMID 17192377.
17.Kilpatrick ES, Bloomgarden ZT, Zimmet PZ. "Is haemoglobin A1c a step forward for
diagnosing diabetes?" BMJ 2009; 339: b4432. DOI: 10.1136/bmj.b4432. PMID 19903702.
18.Gallagher EJ, Bloomgarder ZT, Le Roith D. Review of hemoglobin A1c in the management
of diabetes. Journal of Diabetes 2009; 1: 9-17
19. World Health Organization. Definition, Diagnosis and Classification of Diabetes Mellitus
and its Complications. Part 1: Diagnosis and Classification of Diabetes Mellitus.
WHO/NCD/NCS/99.2 ed. Geneva, World Health Organization, 1999.
20. Hanssen KF, Bangstad HJ, Brinchmann-Hansen O et al. Blood glucose control and diabetic
microvascular complications: long-term effects of near-normoglycaemia. Diabet Med,
1992, 9:697-705.
21. Fox CS, Coady S, Sorlie PD et al. Increasing cardiovascular disease burden due to diabetes
mellitus: the Framingham Heart Study. Circulation, 2007, 115:1544-1550.
22.Zimmet P, Alberti KG, Shaw J. Global and societal implications of the diabetes epidemic.
Nature, 2001, 414:782-787.
23. Alberti KG, Zimmet P, Shaw J. International Diabetes Federation: a consensus on Type 2
diabetes prevention. Diabet Med, 2007, 24:451-463.
24. Preventing chronic diseases: a vital investment. Geneva, World Health Organization, 2005.

25. Diabetes mellitus. Report of a WHO Expert Committee. Geneva, World Health
Organization, 1965.
26. WHO Expert Committee on Diabetes Mellitus. Second Report. Technical Report Series 646.
Geneva, World Health Organization, 1980.
27. Diabetes Mellitus: Report of a WHO Study Group. Technical Report Series 727. Geneva,
World Health Organization, 1985.
28. Definition and diagnosis of diabetes mellitus and intermediate hyperglycaemia. Geneva,
World Health Organization, 2006.
29. Schunemann HJ, Oxman AD, Brozek J et al. Grading quality of evidence and strength of
recommendations for diagnostic tests and strategies. BMJ, 2008, 336:1106-1110.
30. Rahbar S, Blumenfeld O, Ranney HM. Studies of an unusual hemoglobin in patients with
diabetes mellitus. Biochem Biophys Res Commun, 1969, 36:838-843. 24
31. Nathan DM, Kuenen J, Borg R et al. Translating the A1C assay into estimated average
glucose values. Diabetes Care, 2008, 31:1473-1478.
32. Massi-Benedetti M. Changing targets in the treatment of type 2 diabetes. Curr Med Res
Opin, 2006, 22 Suppl 2:S5-13.
33. Nathan DM, Turgeon H, Regan S. Relationship between glycated haemoglobin levels and
mean glucose levels over time. Diabetologia, 2007, 50:2239-2244.
34.International Expert Committee report on the role of the A1C assay in the diagnosis of
diabetes. Diabetes Care, 2009, 32:1327-1334.
35.DETECT-2 Collaboration. Is there a glycemic threshold for diabetic retinopathy?
Diabetologia. In press.
36.McCance DR, Hanson RL, Charles MA et al. Comparison of tests for glycated haemoglobin
and fasting and two hour plasma glucose concentrations as diagnostic methods for
diabetes. BMJ, 1994, 308:1323-1328.
37. McCance DR, Hanson RL, Charles MA et al. Comparison of tests for glycated haemoglobin
and fasting and two hour plasma glucose concentrations as diagnostic methods for
diabetes. BMJ, 1994, 308:1323-1328.
38. Engelgau MM, Thompson TJ, Herman WH et al. Comparison of fasting and 2-hour glucose
and HbA1c levels for diagnosing diabetes. Diagnostic criteria and performance revisited.
Diabetes Care, 1997, 20:785-791.
39.Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus.
Diabetes Care, 1997, 20:1183-1197.
40.Miyazaki M, Kubo M, Kiyohara Y et al. Comparison of diagnostic methods for diabetes
mellitus based on prevalence of retinopathy in a Japanese population: the Hisayama Study.
Diabetologia, 2004, 47:1411-1415.
41.Tapp RJ, Tikellis G, Wong TY et al. Longitudinal association of glucose metabolism with
retinopathy: results from the Australian Diabetes Obesity and Lifestyle (AusDiab) study.
Diabetes Care, 2008, 31:1349-1354.
42.Gallagher EJ, Bloomgarden ZT, Le Roith D. Review of hemoglobin A1c in the management
of diabetes. Journal of Diabetes, 2009, 1:9-17.
43.Roberts WL, De BK, Brown D et al. Effects of hemoglobin C and S traits on eight
glycohemoglobin methods. Clin Chem, 2002, 48:383-385. 25
44.Little RR, Rohlfing CL, Wiedmeyer HM et al. The national glycohemoglobin standardization
program: a five-year progress report. Clin Chem, 2001, 47:1985-1992.
45.Hoelzel W, Weykamp C, Jeppsson JO et al. IFCC reference system for measurement of
hemoglobin A1c in human blood and the national standardization schemes in the United
States, Japan, and Sweden: a method-comparison study. Clin Chem, 2004, 50:166-174.
46.Goldstein DE, Little RR, Lorenz RA et al. Tests of glycemia in diabetes. Diabetes Care, 2004,
27:1761-1773.
47.Diagnosis and classification of diabetes mellitus. Diabetes Care, 2010, 33 Suppl 1:S62- S6